WASHINGTON — The U.S. Senate Committee on Health, Education, Labor, and Pensions voted on a bipartisan basis to pass Senator Hassan’s bipartisan measures that will increase generic drug competition, helping lower prescription drug prices for consumers.
“Granite Staters and Americans need us to take action to lower the cost of prescription drugs, and it’s important that today we advanced bipartisan measures that I authored to increase generic competition, which can lower prescription drug prices for consumers across the board,” said Senator Hassan. “I urge my Senate colleagues to pass this bill, and I will continue working to lower prescription drug costs and hold Big Pharma accountable.”
The package has key measures to lower costs, including:
The package includes a number of additional priorities from Senator Hassan, including: